Skinvisible, Inc.
SKVI
$0.1763
$0.00714.20%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | 13.28% | 45.25% | 9.15% | 26.46% | -3.74% |
| Depreciation & Amortization | 4.26% | 8.51% | 31.11% | 0.00% | 2.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.03% | 43.96% | 10.08% | 25.38% | -3.54% |
| Operating Income | -13.56% | -45.57% | -10.52% | -26.51% | 3.67% |
| Income Before Tax | 3.24% | 203.62% | 0.31% | -9.89% | 80.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.24% | 203.62% | 0.31% | -9.89% | 80.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.24% | 203.62% | 0.31% | -9.89% | 80.83% |
| EBIT | -13.56% | -45.57% | -10.52% | -26.51% | 3.67% |
| EBITDA | -13.84% | -46.97% | -9.58% | -27.69% | 3.89% |
| EPS Basic | 18.13% | 171.00% | 0.32% | -9.87% | 80.82% |
| Normalized Basic EPS | 18.25% | 13.64% | 0.25% | -10.00% | 80.82% |
| EPS Diluted | 18.13% | 169.06% | 0.32% | -15.13% | 80.82% |
| Normalized Diluted EPS | 18.25% | 13.64% | 0.25% | -7.63% | 80.82% |
| Average Basic Shares Outstanding | 18.13% | 45.95% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 18.13% | 45.95% | 0.00% | 2.20% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |